Psilocybin, psychological distress, and suicidality

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

(2015) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The link between use of psychedelic drugs and mental health problems

(2015) Ragnar Nesvåg et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychedelics not linked to mental health problems or suicidal behavior: A population study

(2015) Pål-Ørjan Johansen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Schedule I drug laws on neuroscience research and treatment innovation

(2013) David J. Nutt et al.   NATURE REVIEWS NEUROSCIENCE

Common liability to addiction and “gateway hypothesis”: Theoretical, empirical and evolutionary perspective

(2012) Michael M. Vanyukov et al.   DRUG AND ALCOHOL DEPENDENCE

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.

(2010) Roman Kotov et al.   PSYCHOLOGICAL BULLETIN

Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies

(2009) Enrique F. Schisterman et al.   EPIDEMIOLOGY

Behavioral Disinhibition and the Development of Early-Onset Addiction: Common and Specific Influences

(2008) William G. Iacono et al.   Annual Review of Clinical Psychology

Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies

(2008) Antonio Verdejo-García et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS